Patent
   D773644
Priority
May 23 2013
Filed
Feb 11 2015
Issued
Dec 06 2016
Expiry
Dec 06 2030
Assg.orig
Entity
unknown
22
102
n/a
I claim the ornamental design for a nosepiece unit, as shown and described.

FIG. 1 is a front, top perspective view of a first embodiment of a nosepiece unit showing the new design;

FIG. 2 is a front elevation view thereof;

FIG. 3 is a rear elevation view thereof;

FIG. 4 is a left side view thereof;

FIG. 5 is a right side view thereof;

FIG. 6 is a top plan view thereof;

FIG. 7 is a bottom plan view thereof;

FIG. 8 is a front, top perspective view of a second embodiment showing the new design;

FIG. 9 is a front elevation view thereof;

FIG. 10 is a rear elevation view thereof;

FIG. 11 is a left side view of the nosepiece unit of FIG. 8 thereof;

FIG. 12 is a right side view thereof;

FIG. 13 is a top plan view thereof; and,

FIG. 14 is a bottom plan view thereof.

The broken lines of even length shown in the drawings illustrate portion of the nosepiece unit that form no part of the claimed design. The dash-dot-dash broken lines define the bounds of the claimed design and form no part of the claimed design.

Djupesland, Per Gisle

Patent Priority Assignee Title
10076615, Apr 05 2007 OPTINOSE INC Nasal delivery
10252010, Oct 03 2007 OPTINOSE INC Nasal delivery devices
10286164, May 20 2003 OPTINOSE INC Delivery device and method
10398859, Sep 15 2004 OPTINOSE INC Nasal delivery devices
10525218, Nov 28 2006 OPTINOSE INC Nasal delivery devices
10525240, Jun 28 2018 Sandler Scientific LLC Sino-nasal rinse delivery device with agitation, flow-control and integrated medication management system
10639437, Nov 28 2006 OPTINOSE INC Delivery devices
10639438, Nov 28 2006 OPTINOSE INC Delivery devices
10722667, Apr 05 2007 OPTINOSE INC Nasal administration
10737045, Aug 28 2003 OPTINOSE INC Delivery devices
10765829, Jul 25 2006 OPTINOSE INC Delivery of gases to the nasal airway
10864334, Mar 23 2006 OPTINOSE INC Nasal delivery
11033696, Feb 24 2012 OPTINOSE INC Nasal delivery devices
11083858, Oct 03 2007 OPTINOSE INC Nasal delivery devices
11571531, Feb 23 2005 OPTINOSE INC Powder delivery devices
11602603, Oct 03 2007 OPTINOSE INC Nasal delivery devices
11690969, Jul 25 2006 OPTINOSE INC Delivery of gases to the nasal airway
11707586, Nov 19 2014 OPTINOSE INC Intranasal administration
11730904, Nov 19 2014 OPTINOSE INC Intranasal administration
9949923, Mar 15 2011 OPTINOSE INC Nasal delivery
D809128, May 23 2013 OPTINOSE, INC Nosepiece unit
ER1314,
Patent Priority Assignee Title
5797392, Jan 22 1997 ACERUS BIOPHARMA INC Inhaler
605436,
642748,
6648848, May 27 1997 ACERUS BIOPHARMA INC Inhaler for powdered medicaments
746749,
7784460, Aug 14 2003 OPTINOSE INC Delivery devices
8590530, Sep 15 2005 OPTINOSE INC Nasal delivery devices
8596278, Nov 15 2000 OPTINOSE INC Nasal devices
8800555, Aug 28 2003 OPTINOSE INC Delivery devices
8875704, Apr 05 2007 OPTINOSE INC Nasal administration
8899229, Feb 23 2005 OPTINOSE INC Powder delivery devices
8910629, Jul 25 2006 OPTINOSE INC Delivery of gases to the nasal airway
8978647, Apr 05 2007 OPTINOSE INC Nasal delivery
9010325, Nov 28 2006 OPTINOSE INC Nasal delivery devices
9038630, Nov 28 2006 OPTINOSE INC Delivery devices
9067034, Oct 03 2007 OPTINOSE INC Nasal delivery devices
9072857, Mar 03 1999 OPTINOSE INC Nasal delivery device
9108015, Sep 15 2004 OPTINOSE INC Nasal delivery devices
9119932, Mar 03 1999 OPTINOSE INC Nasal delivery device
9132249, Jul 02 2002 OPTINOSE INC Nasal devices
20040024330,
20040112378,
20040112380,
20040149289,
20040182388,
20050028812,
20050072430,
20050235992,
20060096589,
20060107957,
20060169278,
20070186927,
20080161771,
20090101146,
20090314293,
20100051022,
20100282246,
20110088691,
20130327320,
20140018295,
20140041660,
20140060536,
20140073562,
20140144442,
20140144443,
20140166008,
20140202456,
20140246022,
20150007811,
20150013670,
20150013677,
20150053201,
20150090259,
20150101605,
20150144129,
20150182709,
D530815, Mar 19 2004 OPTINOSE, INC Nasal delivery device
D723156, May 23 2013 OPTINOSE, INC Nasal delivery device
D725769, May 23 2013 OPTINOSE, INC Nasal delivery device
WO51672,
WO197689,
WO2068029,
WO2068030,
WO2068031,
WO2068032,
WO3000310,
WO3020350,
WO3082393,
WO3084591,
WO3090812,
WO2004004814,
WO2004004922,
WO2004060433,
WO2004103447,
WO2005016423,
WO2005021059,
WO2006030210,
WO2006090149,
WO2007083073,
WO2007093784,
WO2007093791,
WO2007099361,
WO2007102089,
WO2007107887,
WO2007125318,
WO2007141541,
WO2008012531,
WO2008065403,
WO2008081326,
WO2008081327,
WO2008122791,
WO2008122795,
WO2009044172,
WO2010029441,
WO2012035427,
WO2012123819,
WO2013124491,
WO2013124492,
WO2013124493,
WO2014155192,
WO9622802,
WO9853869,
//////
Executed onAssignorAssigneeConveyanceFrameReelDoc
Aug 05 2013DJUPESLAND, PER GISLEOptinose, ASASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0372230918 pdf
Feb 11 2015OptiNose AS(assignment on the face of the patent)
Dec 29 2017OptiNose ASATHYRIUM OPPORTUNITIES III ACQUISITION LPSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0449760505 pdf
Sep 12 2019OptiNose ASBIOPHARMA CREDIT PLC, AS COLLATERAL AGENTSECURITY INTEREST SEE DOCUMENT FOR DETAILS 0503710913 pdf
Sep 12 2019ATHYRIUM OPPORTUNITIES III ACQUISITION LPOptiNose ASRELEASE OF SECURITY AGREEMENT RECORDED AT REEL 044976 FRAME 05050503710894 pdf
Mar 13 2023OptiNose ASOPTINOSE, INC ASSIGNMENT OF ASSIGNORS INTEREST SEE DOCUMENT FOR DETAILS 0629740206 pdf
n/a
Date Maintenance Fee Events


n/a
Date Maintenance Schedule